The authors further reported that administration of curcumin at a dose of 400 mg/kg reversed IUGR associated intestinal damage by activating the Nrf2 signaling pathway and stimulating antioxidant enzymes secretion (SOD and CAT), and phase II metabolic enzyme, NQO1 expression. The gene discussed is NFE2L2; the disease is fetal growth restriction.